Wang, Aoli <br/><br/>
Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation.  [electronic resource] 

 -  Oncotarget  Oct 2016 
 - 69760-69769 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.11951  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylamides--pharmacology<br/>Adenine--analogs & derivatives<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>ErbB Receptors--antagonists & inhibitors<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Molecular Conformation<br/>Mutation<br/>Piperidines<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrazoles--chemistry<br/>Pyrimidines--chemistry